Introduction
A variety of metals have been implicated in carcinogenesis in both animal and human studies. It is our purpose here to consider possible molecular mechanisms for the induction of cancer, not only by already identified metal carcinogens, but also by metal ions generally. The reason for this approach is that present knowledge of human metal carcinogens has come about haphazardly, as a result of effects produced in certain places where a population has been subjected to an unusual concentration of certain metals. Carcinogenic metals thus identified resemble in their chemistry and biochemistry other metals that have not been so characterized. Since no molecular mechanism of metal carcinogenesis is presently understood, our best efforts can be devoted to a consideration of those chemical interactions of metals that may lead to cancer. Such interactions can then be considered as bases for hypotheses for carcinogenesis, and are made available for further study.
Chemical Factors in Metal Metabolism
Oxyanions Some inorganic chemicals which have been implicated in carcinogenesis contain elements in relatively high oxidation states, generally as oxyanion salts. In dilute solutions at physiological pH, the stable form ofhexavalent elements is XO42, e. g., X = aqueous solution is a fully-hydrated aquo complex and, as such, is generally considered to be in its most reactive form. Aquo metal ions are generally stable in acid solution but, with the exception of the alkali and alkaline earth ions, all metal ions undergo hydrolysis in neutral or alkaline solution to form hydroxo complexes and may eventually precipitate as the insoluble hydroxides. Hydrolysis of metal ions may be prevented if ligands are present that forn sufficiently stable complexes or chelates to displace water of hydration and thus compete with hydrolytic tendencies. Generally, chelates are more stable, especially in dilute solution. Ligands differ in effectiveness, depending on their affinities for hydrogen ions and for any other metal ions present, that compete for the metal ion under consideration. The thermodynamic parameters that measure quantitatively the extent to which these competing reactions occur, and thus define the metal speciation as a function of solution conditions, may be found in compilations of stability constants (6) (7) (8) .
If the necessary stability constants are available, metal ion speciation may be determined with the aid of equations of the type described in the commissioned paper by Martell (9) and high-speed computers.
The aqueous solutions found in various physiological compartments generally contain a large number of small molecules and macromolecules having affinity for metal ions. In only a few cases are there sufficient stability data to carry out rough, approximate calculations of metal speciation. Thus, for blood serum it has been possible to make estimates of metal ion speciation with a "four-metal model" (copper, zinc, calcium, and magnesium). Even such crude calculations are hampered by lack of information on the stabilities of complexes of the many amino acids present. Especially unfortunate is the lack of information on the stabilities of metal complexes of the serum proteins, which seem to carry large fractions of some of the metal ions present.
For other biological fluids of importance in absorption, metabolism and possible carcinogenic effects of metal compounds, very little information is available for the determination of metal speciation (10) (11) . Therefore, stability constants and ligand dissociation constants are needed for the metalbinding species that are present in the important physiological compartments, and under the conditions that exist in such systems.
Kinetic Factors That Affect Speciation
Early in the development ofcoordination chemistry, it was recognized that complexes of certain metal 28 ions, notably Cr(III), Co(III), Rh(III), Ir(III), Pd(II), and Pt(IV) are formed significantly more slowly than those with other metal ions [e.g., Mn(II), Fe(II), Cu(II), Zn(II), Cd(II), Hg(II)] for any given ligand (e.g., NH3). Moreover, significant differences in reaction rates are sometimes observed among the different oxidation states of a given metal; ligand exchange rates for complexes with labile Cr(II) and Co(II) are up to 14 orders of magnitude greater than the rates of corresponding reactions of inert Cr(III) and Co(III). These terms are applied to homogeneous reactions in solution, and do not reflect other kinetic and thermodynamic effects which control the rate of dissolution of sparingly soluble salts.
For both substitution inert and substitution labile complexes, the thermodynamically favored product will eventually form, but for substitution inert complexes, "eventually" may exceed the lifetime of organisms in a biological sample. For substitution inert complexes, then, the first products observed in ligand exchange processes are ormed under kdnetic control, whereas for substitution labile complexes, the first observed product is forned under thermodynamic control. A convenient simplification reduces the difference between substitution inert and substitution labile complexes to the differences in the activation energy for the ligand substitution process. These differences may be related to the electronic configuration of the metal ion. Thus, complexes of metals with the 3d electrons and highly covalent complexes with metals having six or eight electrons are spin paired (diamagnetic) and typically substitution inert.
The relationship between electronic configuration and activation energy for ligand exchange processes explains the change from substitution inertness in Cr(III) and Co(III) to Smith et al. (12) , the methylated compounds occur in the same proportion, about 66% of total arsenic in the urine from workers exposed to low and high levels of airborne arsenic trioxide, indicating that the rate of biotransformation did not change with dose. However, a table in their paper shows that, in fact, the ratio As(III)/As(V) increases with increasing exposure. Exposure to hexavalent chromium is associated with an increased occurrence of lung cancer among occupationally exposed workers. As discussed in the working paper by Jennette (13) , Cr(VI) in the form of an oxyanion can penetrate cell membranes, whereas Cr(III) compounds do not penetrate. In liver cells Cr(VI) is reduced to Cr(III), probably mediated through the P-450 system (3). However, the target organ is the lung, and it has been shown that microsomes from rat lung do not deactivate hexavalent chromium with regard to mutagenicity (14) .
Membrane Transport
Small molecules may enter cells by passive diffusion and/or by mediated permeation (15) . Generally, neutral molecules can diffuse across membranes and be easily taken up by cells. Anions seem to be able to diffuse across membranes much more readily than cations. Specific anion transport systems and cation treansport systems are known to be responsible for membrane penetration as phosphate, sulfate, magnesium, calcium, sodium, and potassium (16) . Macromolecules and particles may enter cells by endocytosis. Efficient homeostatic mechanisms exist for essential elements such as copper, zinc, and iron (17) . Proteins which specifically bind metals, such as calcium-binding protein and zinc-binding protein, have been identified as transporter molecules (18) .
Oxyanions, such as chromate and arsenate, may enter cells using the phosphate and sulfate transport systems normally found in membranes (13) . Cell membranes are relatively impermeable to Cr(III) complexes (19) . The ligation and form of a metal can significantly affect the ability of a metal to penetrate the membrane. Neutral complexes, such as the antitumor agents cis-dichlorodiammine platinum (II), and 3-ethoxy-2-oxobutyraldehydebis(thiosemicarbazonato)copper (II), readily cross membranes, whereas the positively charged species tetra-ammineAugust 1981 platinum(II) and hexaquocopper(II) are not taken up by cells (20) . Ionophores, such as the cyclic neutral peptide antibiotic valinomycin and neutral macrotetrolide antibiotic nonactin, complex alkali metals and transport them through membranes (21) . The anion associated with the cation affects the rate of diffusion of these complexes through membranes and may form an ion-pair with the ionophore-cation complex (22) . Heme, a neutral Fe(II) complex, easily crosses the mitochondrial membrane and enters peroxisomes (23) .
Iron bound to transferrin is taken up by reticulocytes by endocytosis (24) . Particles of nickel subsulfide, a-Ni3S2, in mice were found within macrophases (26) . The role of phagosomes in nickel mobilization is not understood.
Proposed Models of Carcinogenesis
Direct Reactions of Metals with Nucleic Acids DNA. Much evidence indicates that the primary locus of carcinogenesis is the DNA molecule. It is, therefore, appropriate to direct attention to the ways in which metal ions can produce potentially deleterious effects on DNA. These effects could be produced either by direct interaction with DNA, or indirectly through the influence of metabolic events that eventually lead to DNA damage.
The DNA molecule presents two types of binding sites to metal ions for direct interaction: the phosphate groups in the deoxyribosephosphate backbone and a vareity of electron donor groups on the bases. Metals react with both types of sites, and reaction with either can lead to potentially deleterious effects (27) . Many metals react with both phosphates and bases; but soft metals [for definition, see Martell (9) ] tend to favor bases, and hard metals tend to favor the phosphates.
Specific binding sites that have been demonstrated on the bases are the N(3), and occasionally 0(2) positions of pyrimidines, and the N(7) and N(1) positions of purines. Frequently, changes in reaction conditions result in the binding of metal to a different site. Chelation by binding to adjacent sites has been postulated, but evidence produced so far has not supported this type of complexation (28) .
It has been demonstrated that metal-base binding can lead to the formation of crosslinks between the DNA strands [e.g., with Cu(II), Ni(II), Zn(II), Cd(II), Pt(II) (27) ]. Such binding is potentially damaging, as is the linkage of adjacent bases by 29 platinum complexes used as antitumor agents (29) . Binding of metals to the bases dramatically changes the cleavage specificity of enzymes that act on DNA (e.g., Cu(II), Hg(II)).
While metal binding to phosphate groups stabilizes the DNA double helix, an excess of metal ions [e.g., Mg(II)] can bring about the mispairing of bases (30, 31) . The potential of damage from this phenomenon in replication, transcription, as well as in translation, is obvious and has been observed in DNA synthesis.
Metals, and most profoundly base binding metals [e.g., Cu(II), Pt(II)] affect the close packing of DNA molecules in DNA-protein complexes (32) and could, therefore, influence the arrangement of DNA and protein in the chromosome.
Both DNA replication and transcription (i.e., RNA synthesis) required the participation of metal ions. Several metals can serve this function, with somewhat different results. Whereas magnesium leads to high fidelity in both base and sugar incorporation, manganese can produce infidelity in both processes (28) . For example, Mn(II) causes incorporation of deoxynucleotides into RNA (32) .
Modification of the DNA template by metal binding (as observed for Pt(II)) leads to major decreases in the lengths of the RNA chains produced in transcription (33) .
The antitumor properties of certain platinum complexes have received much attention and are believed to result from DNA interaction. These studies are also relevant to carcinogenesis (34) .
In summary, metal ions binding to DNA produce many damaging effects on the DNA and, while necessary in replication and transcription, can cause errors to occur in these processes. It must be emphasized that many of these studies are in vitro studies. To determine their true relevance to carcinogenesis, work outlined later under Recommendations for Future Research is required. It should also be pointed out that concentrations of metal ions required to produce a similar effect in vitro and in vivo could be very different.
RNA. Many of the effects of metal ions on DNA also occur through binding with RNA (e.g., crosslinking, mispairing). However, RNA contains an additional binding site not present on DNA, the 2' OH group. The major effect of this group, nevertheless, for potentially deleterious reactions with metal ions is that it makes possible the degradation of RNA by phosphate-binding metals [e.g., Zn(II), Pb(II), Ce(III)], which cleave the phosphodiester linkage through the intermediate formation of a 2',3'-cyclic phosphate (27) .
Since mispairing of bases at high metal ion concentration (30) can lead to error in the incorpo-30 ration of amino acids into proteins, metal ions can also induce errors in translation. In fact, metal ions are involved in all of the complicated steps in protein synthesis and, in the wrong concentrations, could lead to errors in any of these steps.
Indirect Modes
Effects on DNA Repair. Metals such as Ni(II), Mn(II), Cr(III), Co(II), Be(II), Cd(II), and Pb(II) decrease the fidelity of DNA synthesis in vitro (35) . The incorporation of noncomplementary nucleotides in the presence of these metals by E. coli DNA polymerase I suggests a possible pathway to somatic mutation by metals via misreplication. In addition, decreases in the fidelity of DNA repair polymerases by metals suggests a possible pathway whereby metals might act as comutagens. Be(II) formed a strong complex with DNA polymerase I which consequently functioned improperly (36) . DNA polymerases are Zn-metalloproteins, and substitution of another metal, e.g., cobalt, for the zinc would be expected to change the activity and/or specificity of the enzymes. Inorganic species which inhibit RNA polymerase activity could inhibit the inducible "SOS" repair system which is "errorprone." DNA synthesis by mammalian DNA polymerase a is inhibited by sulfhydryl reagents. Many inorganic agents which are known to inhibit sulfhydryl enzymes could be expected to inhibit DNA synthesis and repair in mammalian cells, e.g., arsenite, selenite, cadmium and mercury.
Modification of Metabolic Processes. Several chemical mechanisms exist whereby some metals may inhibit or enhance the carcinogenic effects of other metals or nonmetals. Furthermore, some metals and their complexes may alter the apparent activity to known organic carcinogens. The ultimate manifestation of these processes depends on physicochemical, biochemical, and pharnacodynamic considerations as outlined below.
Metal-Metal Exchange. Metal-metal exchange may be involved in release or fixation of carcinogenic metals in biological systems. When one metal displaces another, the net result can either be fixation of the metal or its elimination. In these cases we are referring to labile metal combinations and not the practically undisplaceable metals present in metalloenzymes. The or unusual oxidation states. Generally, when low concentrations of metals are involved, the relatively higher levels of ligands will react with transition metals to form mixed or ternary complexes with their own capacity to transport metals.
Ceruloplasmin, a blue protein from human serum, has been regarded as a primary copper transport and storage agent. A molecule of this protein of molecular weight up to 600,000 contains 8 to 10 strongly bound copper ions at the active sites, which may have a significant role in metal storage and transport and also in stabilizing the unusually large multi-component protein (41).
It should be noted that complexed metal ions, after entrance into the cells, may generate free radicals (42) or modify their half-lives or turnover time, thus altering normal scavenging mechanisms.
Free radicals and associated H202 produced by metal ions can damage and inactivate DNA (43-47). Biochemical Effects. Among the roles of metal ions in biology, redox functions, participation in hydrolytic processes, the activation of small molecules, and various structural functions have been identified. The redox role is limited to metal ions which may exist in different oxidation states [e.g., Fe(II), Fe(III); Cu(I), Cu(II)]. Variable oxidation states are not essential for metal ion participation in hydrolytic processes and may or may not be required for the activation of small molecules. Those metal ions, for which the only known role is the stabilization of a macromolecular structure, are characterized by a single stable oxidation state.
MICROSOMALENZYMES. Chronicexposuretometals may raise or lower the activity of microsomal enzymes and thereby modify the chemical trans 
Recommendations for Future Research
Metal Speciation A large body of equilibrium data is needed to identify and determine concentration levels of metal ions in biological fluids. In order to provide an approach to this problem, stability constants and acid-base equilibrium constants for the interaction of carcinogenic metal ions with ligands found in physiological solutions should be determined under the conditions that prevail in such solutions. These should be measured under conditions applicable to blood serum, kidney, stomach, lung fluid, intestine, and the cell nucleus. These measurements should be made for the major small molecules and macromolecules that are present in these physiological compartments. Appropriate kdnetic factors in reaching equilibrium in these systems should be determined.
Dose Effect-Response Relationships
Studies are required to determine dose effects on speciation of carcinogenic metals in biological systems. 32 Studies are required to determine the speciation of carcinogenic metallic compounds in malignant and nonmalignant tissues from autopsied exposed workers.
Enzymes Involved in Metabolism
The enzymes involved in the redox activation of inorganic carcinogens should be identified. The mechanisms by which the enzymes change the formal oxidation state of the element, the cofactors involved, and the nature of the active site should be determined. The form of the element after enzyme metabolism should be characterized. The electron transfer processes should be studied and intermediates (if any) should be identified.
Enzymes involved in the methylation of inorganic carcinogens should be identified. The mechanisms by which these enzymes function (e.g., nature of active site, methyl-cofactor, methyl transfer to element) should be determined. Nature of the inorganic substrates and alkylated products should be determined (e.g., As).
Membrane Transport
Systematic studies of effects of ligands on transport of metal cations, e.g., Cr(III), across membranes should be made. Mechanisms by which oxyanions use phosphate and sulfate transport systems (or by which metallic cations can share transport systems of other physiological ions such as calcium or magnesium) and possibly alter these systems should be determined. The manner by which metals can use other transporters should be investigated.
Mechanisms of metal homeostasis, e.g., Cr and Zn, should be studied.
DNA-RNA
Interactions of DNA with some of the known metal carcinogens have received relatively little attention. Studies with metals such as Be, Ni, Cr, etc., should, therefore, be carried out and binding sites should be determined.
The metal binding to DNA demonstrated in vitro should be examined in in vivo systems; where possible, the consequences, e.g., altered protein synthesis, should be studied.
These studies should compare normal with metalinduced cells.
Modification of Metabolic Processes
Numerous substitutes for the preferred metal ion in proteins have been shown. Almost no informaEnvironmental Health Perspectives tion, however, is available to demonstrate that these reactions occur in mammalian systems through routes of administration typical of occupational or environmental exposure.
Incorporation of carcinogenic metals into proteins, and into enzymes in particular, following in vivo exposure of animals needs to be examined. These proteins need to be identified, and the metal binding sites need to be characterized. The effects of substitution on the function of the enzymes need to be examined. Possible effects include inhibition or enhancement of activity and changes in enzyme specificity. The possibility that such alterations could result in a carcinogenic response needs to be examined.
The carcinogenic activity of weak to strong organic carcinogens sorbed on particulates prepared from essential and nonessential metals should be examined. The metal particulates of known particle sizes would consist of sulfides, oxides, and other insoluble states, especially the types known to be present in the natural or occupational environment.
The routes of administration of the particulates would include, as a miniimum, the oral and respiratory. Suitable controls must be considered.
The modifying actions of soluble forms of metals on the carcinogenic activity of weak to strong carcinogens should be examined. The time of administration of the metals relative to the carcinogen would be varied.
The ability of binary metal chelates to transport or deliver selected carcinogens via mixed complex formation should be ascertained.
The effect of the chronic administration of low levels of metals on microsomal enzymes, organelle activity, and other such indicators of biochemical alterations should be studied.
